|
US4880935A
(en)
|
1986-07-11 |
1989-11-14 |
Icrf (Patents) Limited |
Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
|
|
IL89220A
(en)
|
1988-02-11 |
1994-02-27 |
Bristol Myers Squibb Co |
Anthracycline immunoconjugates, their production and pharmaceutical compositions containing them
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
WO1993003741A1
(en)
|
1991-08-22 |
1993-03-04 |
Becton, Dickinson & Company |
Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
CA2132500A1
(en)
|
1994-09-20 |
1996-03-21 |
David Lockwood Manning |
Methods for predicting the behaviour of breast tumours
|
|
EP0871490B1
(en)
|
1995-12-22 |
2003-03-19 |
Bristol-Myers Squibb Company |
Branched hydrazone linkers
|
|
US6130237A
(en)
|
1996-09-12 |
2000-10-10 |
Cancer Research Campaign Technology Limited |
Condensed N-aclyindoles as antitumor agents
|
|
CA2269634C
(en)
|
1996-10-31 |
2010-08-17 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the breast
|
|
US6066778A
(en)
|
1996-11-06 |
2000-05-23 |
The Regents Of The University Of Michigan |
Transgenic mice expressing APC resistant factor V
|
|
WO1998034118A1
(en)
|
1997-01-30 |
1998-08-06 |
Yale University |
Diagnostic methods and compositions based on the distribution of rad51
|
|
WO1999023230A1
(en)
|
1997-10-31 |
1999-05-14 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the breast
|
|
JP2001523472A
(ja)
|
1997-11-18 |
2001-11-27 |
アボット・ラボラトリーズ |
乳房の疾患の検出に有用な試薬および方法
|
|
CA2316397A1
(en)
|
1997-12-24 |
1999-07-08 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
|
WO2000008210A1
(en)
|
1998-08-04 |
2000-02-17 |
Diadexus Llc |
A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
|
|
EP1121437B1
(en)
|
1998-10-15 |
2008-02-20 |
Novartis Vaccines and Diagnostics, Inc. |
Metastatic breast and colon cancer regulated genes
|
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
|
US6762020B1
(en)
|
1999-03-15 |
2004-07-13 |
Protein Design Labs, Inc. |
Methods of diagnosing breast cancer
|
|
US20040141983A1
(en)
|
1999-03-15 |
2004-07-22 |
Protein Design Labs, Inc. |
Compositions against cancer antigen LIV-1 and uses thereof
|
|
IL150592A0
(en)
|
2000-01-25 |
2003-02-12 |
Genentech Inc |
Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
|
|
WO2001096372A2
(en)
|
2000-06-13 |
2001-12-20 |
University College Cardiff Consultants Ltd |
Zinc transporters proteins and their use in medicinal preparations
|
|
US6964849B2
(en)
|
2001-01-11 |
2005-11-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
AU2002322280A1
(en)
|
2001-06-21 |
2003-01-21 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
AU2002324451A1
(en)
|
2001-06-21 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
WO2003075855A2
(en)
|
2002-03-08 |
2003-09-18 |
Protein Design Labs, Inc. |
Antibodies against cancer antigen tmeff2 and uses thereof
|
|
ES2369542T3
(es)
|
2002-07-31 |
2011-12-01 |
Seattle Genetics, Inc. |
Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
|
|
RS20050577A
(sr)
|
2003-01-27 |
2007-09-21 |
Biogen Idec Ma Inc., |
PREPARATI I POSTUPCI ZA TRETIRANjE KANCERA KORIŠĆENjEM IGSF9 I LIV-1
|
|
WO2004067564A2
(en)
|
2003-01-29 |
2004-08-12 |
Protein Design Labs, Inc. |
Compositions against cancer antigen liv-1 and uses thereof
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
US7371381B2
(en)
|
2003-12-12 |
2008-05-13 |
Amgen Inc. |
Anti-galanin antibodies and uses thereof
|
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
|
US20060222653A1
(en)
|
2004-11-12 |
2006-10-05 |
Xencor, Inc. |
Antibodies operably linked to selected chemoattractants
|
|
WO2006124269A2
(en)
|
2005-05-16 |
2006-11-23 |
Amgen Fremont Inc. |
Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
|
|
CN101309933A
(zh)
*
|
2005-09-07 |
2008-11-19 |
米迪缪尼有限公司 |
毒素偶联的Eph受体抗体
|
|
KR20080080482A
(ko)
*
|
2005-09-07 |
2008-09-04 |
메디뮨 엘엘씨 |
독소가 컨쥬게이트된 ｅｐｈ 수용체 항체
|
|
KR20090010194A
(ko)
|
2006-04-13 |
2009-01-29 |
노바티스 백신즈 앤드 다이아그노스틱스, 인크. |
암의 치료, 진단 또는 검출 방법
|
|
PL2099823T5
(pl)
|
2006-12-01 |
2023-02-20 |
Seagen Inc. |
Wariant środków wiążących cel i jego zastosowania
|
|
US20090068195A1
(en)
|
2007-04-23 |
2009-03-12 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
TW200944231A
(en)
|
2007-11-30 |
2009-11-01 |
Glaxo Group Ltd |
Antigen-binding constructs
|
|
WO2010003773A1
(en)
|
2008-06-16 |
2010-01-14 |
Siemens Medical Solutions Diagnostics Gmbh |
Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer
|
|
WO2010045234A1
(en)
|
2008-10-14 |
2010-04-22 |
University Of Louisville Research Foundation, Inc. |
Methods of optimizing treatment of estrogen-receptor positive breast cancers
|
|
WO2010069858A1
(en)
|
2008-12-19 |
2010-06-24 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition
|
|
US8642270B2
(en)
|
2009-02-09 |
2014-02-04 |
Vm Institute Of Research |
Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer
|
|
US20110165566A1
(en)
|
2009-07-09 |
2011-07-07 |
Wittliff James L |
Methods of optimizing treatment of breast cancer
|
|
JP5996429B2
(ja)
|
2009-09-03 |
2016-09-21 |
ジェネンテック， インコーポレイテッド |
関節リウマチの治療、診断及びモニターするための方法
|
|
PT3156420T
(pt)
|
2010-12-06 |
2019-05-27 |
Seattle Genetics Inc |
Anticorpos humanizados a liv-1 e seu uso para tratar o cancro
|
|
WO2012125712A2
(en)
|
2011-03-14 |
2012-09-20 |
Respira Health, Llc |
Lung tumor classifier for current and former smokers
|
|
HUE044352T2
(hu)
*
|
2011-10-14 |
2019-10-28 |
Hoffmann La Roche |
Pertuzumab, Trastuzumab, Docetaxel és Carboplatin korai stádiumú mellrák kezelésére
|
|
WO2013170263A2
(en)
|
2012-05-11 |
2013-11-14 |
Merrimack Pharmaceuticals, Inc. |
Dosage and administration of bispecific scfv conjugates in combination with anti-cancer therapeutics
|
|
DE202012006349U1
(de)
|
2012-07-03 |
2013-07-05 |
Schuster Engineering Gmbh |
Schiffsladeanordnung
|
|
DK2839860T3
(da)
|
2012-10-12 |
2019-06-17 |
Medimmune Ltd |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
US10898555B2
(en)
|
2013-07-02 |
2021-01-26 |
Japanese Foundation For Cancer Research |
Cellular immunity inducing vaccine
|
|
US11185594B2
(en)
*
|
2014-04-10 |
2021-11-30 |
Daiichi Sankyo Company, Limited |
(Anti-HER2 antibody)-drug conjugate
|
|
CA3084495A1
(en)
*
|
2017-12-01 |
2019-06-06 |
Seattle Genetics, Inc. |
Humanized anti-liv1 antibodies for the treatment of breast cancer
|
|
EA202191257A1
(ru)
|
2018-11-07 |
2021-12-06 |
Криспр Терапьютикс Аг |
Противораковая терапия на основе иммуноцитов, связывающих liv1
|
|
GB201908208D0
(en)
|
2019-06-10 |
2019-07-24 |
Univ College Cardiff Consultants Ltd |
An anti-mitotic agent
|
|
MX2022006891A
(es)
|
2019-12-09 |
2022-09-09 |
Seagen Inc |
Terapia combinada con liv1-adc y antagonista de pd-1.
|